Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCNA2 | P20248 | 3/20 | 0.59 |
| ▸ | CDK2 | P24941 | 3/20 | 0.59 |
| ▸ | NTRK1 | P04629 | 6/20 | 0.57 |
| ▸ | IGF1R | P08069 | 2/20 | 0.54 |
| ▸ | JAK2 | O60674 | 2/20 | 0.53 |
| ▸ | JAK3 | P52333 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12878463 | 0.88 | CCNA2 (0.74) | CCNA2CDK2NTRK1IGF1R | |
| SCHEMBL15827556 | 0.88 | NTRK1 (0.54) | CCNA2CDK2NTRK1IGF1RJAK2 | |
| SCHEMBL2068963 | 0.86 | NTRK1 (0.57) | CCNA2CDK2NTRK1IGF1RJAK2 | |
| SCHEMBL1164700 | 0.86 | CCNA2 (0.54) | CCNA2CDK2NTRK1IGF1RJAK2 | |
| SCHEMBL1165110 | 0.86 | NTRK1 (0.57) | CCNA2CDK2NTRK1IGF1RJAK2 | |
| SCHEMBL1163949 | 0.86 | NTRK1 (0.57) | CCNA2CDK2NTRK1IGF1RJAK2 | |
| SCHEMBL1164457 | 0.86 | CCNA2 (0.54) | CCNA2CDK2NTRK1IGF1RJAK2 | |
| SCHEMBL12783919 | 0.85 | CCNA2 (0.64) | CCNA2CDK2NTRK1IGF1RJAK2 | |
| SCHEMBL1163954 | 0.84 | CCNA2 (0.80) | CCNA2CDK2NTRK1IGF1RJAK2 | |
| SCHEMBL1163704 | 0.84 | IGF1R (0.57) | CCNA2CDK2NTRK1IGF1RJAK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011019405-A1 | PYRIMIDINE COMPOUNDS AS TUBERCULOSIS INHIBITORS | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2011-02-17 | — | — | WO | disclosed |